Correlation Between Oncorus and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Oncorus and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Oncorus and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Cadrenal Therapeutics,.
Diversification Opportunities for Oncorus and Cadrenal Therapeutics,
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncorus and Cadrenal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Oncorus i.e., Oncorus and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Oncorus and Cadrenal Therapeutics,
If you would invest 1,423 in Cadrenal Therapeutics, Common on December 29, 2024 and sell it today you would earn a total of 423.00 from holding Cadrenal Therapeutics, Common or generate 29.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Oncorus vs. Cadrenal Therapeutics, Common
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cadrenal Therapeutics, |
Oncorus and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Cadrenal Therapeutics,
The main advantage of trading using opposite Oncorus and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |